https://www.limswiki.org/api.php?hidebots=1&days=7&limit=50&target=Laboratory_information_system&action=feedrecentchanges&feedformat=atomLIMSWiki - Changes related to "Laboratory information system" [en]2024-03-28T18:19:01ZRelated changesMediaWiki 1.36.1https://www.limswiki.org/index.php?title=21_CFR_Part_11&diff=60567&oldid=4545621 CFR Part 112024-03-28T01:54:06Z<p>Text replacement - "\[\[Agilent Technologies, Inc.(.*)" to "[[Vendor:Agilent Technologies, Inc.$1"</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:54, 28 March 2024</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td>
<td colspan="2" class="diff-lineno">Line 7:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>By the early 1990s, food and drug manufacturers approached the U.S. Food and Drug Administration (FDA) about the possibility of electronic submissions with electronic signatures. However, at that time the government did not allow for digital signatures. In July 1992, the FDA began soliciting comments about the process of using electronic signatures.<ref name="GCN00Art">{{cite web |url=https://gcn.com/2000/06/fda-offers-electronic-option/276201/ |title=FDA offers electronic option |author=Jackson, W. |publisher=GCN |date=01 June 2000 |accessdate=07 January 2022}}</ref></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>By the early 1990s, food and drug manufacturers approached the U.S. Food and Drug Administration (FDA) about the possibility of electronic submissions with electronic signatures. However, at that time the government did not allow for digital signatures. In July 1992, the FDA began soliciting comments about the process of using electronic signatures.<ref name="GCN00Art">{{cite web |url=https://gcn.com/2000/06/fda-offers-electronic-option/276201/ |title=FDA offers electronic option |author=Jackson, W. |publisher=GCN |date=01 June 2000 |accessdate=07 January 2022}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>In March 1997, the FDA issued Part 11 regulations which, in the words of the FDA, were "intended to permit the widest possible use of electronic technology, compatible with FDA's responsibility to protect the [[Public health informatics|public health]]."<ref name="RegInfo_Part11_FDA" /> Various keynote speeches by FDA insiders early in the 21st century (in addition to compliance guides and draft guidance documents)<ref name="RegInfo_Part11_FDA" /> as well as strong efforts by the FDA to motivate industry to move to e-filing<ref name="IWEfilingFDA">{{cite web |url=https://www.informationweek.com/it-life/fda-moving-to-e-filing |title=FDA Moving To E-Filing |author=Greenemeier, L. |publisher=InformationWeek |date=25 February 2002 |accessdate=07 January 2022}}</ref> resulted in many companies like Eli Lilly<ref name="IWLillyPart11">{{cite web |url=https://www.informationweek.com/it-life/lilly-cures-inefficiency-with-it |title=Lilly Cures Inefficiency With IT |author=Greenemeier, L. |publisher=InformationWeek |date=18 February 2002 |accessdate=07 January 2022}}</ref>, [[Agilent Technologies, Inc.|Agilent Technologies]]<ref name="LabNetAgilent00">{{cite web |url=https://www.laboratorynetwork.com/doc/agilent-introduces-security-pack-for-analytic-0001 |title=Agilent Introduces Security Pack for Analytical Laboratories |publisher=Laboratory Network |date=20 June 2000 |accessdate=15 April 2020}}</ref>, and other businesses rapidly being forced to change their methods and systems to adapt to the new standards.<ref name="RegInfo_Part11_FDA" /><ref name="CEPart11Art">{{cite web |url=https://www.controleng.com/articles/im-from-the-government-and-im-here-to-help-you/ |title='I'm from the Government, and I'm Here to Help You!' |author=Harrold, D. |work=Control Engineering |date=01 April 2002 |accessdate=15 April 2020}}</ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>In March 1997, the FDA issued Part 11 regulations which, in the words of the FDA, were "intended to permit the widest possible use of electronic technology, compatible with FDA's responsibility to protect the [[Public health informatics|public health]]."<ref name="RegInfo_Part11_FDA" /> Various keynote speeches by FDA insiders early in the 21st century (in addition to compliance guides and draft guidance documents)<ref name="RegInfo_Part11_FDA" /> as well as strong efforts by the FDA to motivate industry to move to e-filing<ref name="IWEfilingFDA">{{cite web |url=https://www.informationweek.com/it-life/fda-moving-to-e-filing |title=FDA Moving To E-Filing |author=Greenemeier, L. |publisher=InformationWeek |date=25 February 2002 |accessdate=07 January 2022}}</ref> resulted in many companies like Eli Lilly<ref name="IWLillyPart11">{{cite web |url=https://www.informationweek.com/it-life/lilly-cures-inefficiency-with-it |title=Lilly Cures Inefficiency With IT |author=Greenemeier, L. |publisher=InformationWeek |date=18 February 2002 |accessdate=07 January 2022}}</ref>, [[<ins style="font-weight: bold; text-decoration: none;">Vendor:</ins>Agilent Technologies, Inc.|Agilent Technologies]]<ref name="LabNetAgilent00">{{cite web |url=https://www.laboratorynetwork.com/doc/agilent-introduces-security-pack-for-analytic-0001 |title=Agilent Introduces Security Pack for Analytical Laboratories |publisher=Laboratory Network |date=20 June 2000 |accessdate=15 April 2020}}</ref>, and other businesses rapidly being forced to change their methods and systems to adapt to the new standards.<ref name="RegInfo_Part11_FDA" /><ref name="CEPart11Art">{{cite web |url=https://www.controleng.com/articles/im-from-the-government-and-im-here-to-help-you/ |title='I'm from the Government, and I'm Here to Help You!' |author=Harrold, D. |work=Control Engineering |date=01 April 2002 |accessdate=15 April 2020}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>However, many entities expressed concerns about the Title 11 conditions, including concerns the regulations would "unnecessarily restrict" the use of technology, add significant compliance costs beyond what was intended, and stifle technological innovation while reducing public health benefit.<ref name="RegInfo_Part11_FDA" /> In November 2002, the FDA released the guidance document "Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures, Electronic Copies of Electronic Records" to the public for commenting.<ref name="CEGuideDocFDA1">{{cite web |url=https://www.controleng.com/articles/fda-releases-21-cfr-part-11-guidance-document/ |title=FDA releases 21 CFR Part 11 guidance document |author=Control Engineering Staff |work=Control Engineering |date=03 January 2003 |accessdate=15 April 2020}}</ref> On February 3, 2003, the FDA withdrew that document, stating "we wanted to minimize industry time spent reviewing and commenting on the draft guidance when that draft guidance may no longer represent our approach under the [current good manufacturing practice] initiative," adding it would afterwards "intend to exercise enforcement discretion with regard to certain Part 11 requirements."<ref name="RegInfo_Part11_FDA" /> Further guidance documents were withdrawn later that month, culminating in a final guidance document in August 2003 stating the government body would re-examine Part 11 and make necessary changes.<ref name="RegInfo_Part11_FDA" /><ref name="inPharmaFDAFinal03">{{cite web |url=https://www.outsourcing-pharma.com/Article/2003/09/05/FDA-plans-to-amend-21-CFR-Part-11-rules |title=FDA plans to amend 21 CFR Part 11 rules |work=Outsourcing-Pharma |date=04 September 2003 |accessdate=15 April 2020}}</ref> However, the FDA reiterated despite its retraction of the guidance documents "21 CFR Part 11 is not going away, and neither is the agency's demand for electronic record integrity."<ref name="QDPart11StillEnforced">{{cite web |url=https://www.qualitydigest.com/july03/articles/04_article.shtml |title=Quality Assurance, Safety and 21 CFR Part 11: These three old friends are here to stay |author=June, T.M. |work=Quality Digest |date=July 2003 |accessdate=15 April 2020}}</ref> The retraction of guidance and change in policy, however, led many IT members in the pharmaceutical and life sciences industry in late 2004 to state one of the key problems they face as the lack of clear guidelines from the FDA about what is required for compliance.<ref name="SNSSurveyUKIT">{{cite web |url=http://snseurope.info/article/12833/Complying-with-US-Food-and-Drug-Administration(FDA)-data-regulations-is-proving-a-struggle-for-IT-departments-in-pharmaceutical-and-life-science-companies |title=Complying with US Food and Drug Administration(FDA) data regulations is proving a struggle for IT departments in pharmaceutical and life science companies |publisher=Storage Networking Solutions |date=17 November 2004 |accessdate=06 April 2013}}{{Dead link|April 2020}}</ref></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>However, many entities expressed concerns about the Title 11 conditions, including concerns the regulations would "unnecessarily restrict" the use of technology, add significant compliance costs beyond what was intended, and stifle technological innovation while reducing public health benefit.<ref name="RegInfo_Part11_FDA" /> In November 2002, the FDA released the guidance document "Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures, Electronic Copies of Electronic Records" to the public for commenting.<ref name="CEGuideDocFDA1">{{cite web |url=https://www.controleng.com/articles/fda-releases-21-cfr-part-11-guidance-document/ |title=FDA releases 21 CFR Part 11 guidance document |author=Control Engineering Staff |work=Control Engineering |date=03 January 2003 |accessdate=15 April 2020}}</ref> On February 3, 2003, the FDA withdrew that document, stating "we wanted to minimize industry time spent reviewing and commenting on the draft guidance when that draft guidance may no longer represent our approach under the [current good manufacturing practice] initiative," adding it would afterwards "intend to exercise enforcement discretion with regard to certain Part 11 requirements."<ref name="RegInfo_Part11_FDA" /> Further guidance documents were withdrawn later that month, culminating in a final guidance document in August 2003 stating the government body would re-examine Part 11 and make necessary changes.<ref name="RegInfo_Part11_FDA" /><ref name="inPharmaFDAFinal03">{{cite web |url=https://www.outsourcing-pharma.com/Article/2003/09/05/FDA-plans-to-amend-21-CFR-Part-11-rules |title=FDA plans to amend 21 CFR Part 11 rules |work=Outsourcing-Pharma |date=04 September 2003 |accessdate=15 April 2020}}</ref> However, the FDA reiterated despite its retraction of the guidance documents "21 CFR Part 11 is not going away, and neither is the agency's demand for electronic record integrity."<ref name="QDPart11StillEnforced">{{cite web |url=https://www.qualitydigest.com/july03/articles/04_article.shtml |title=Quality Assurance, Safety and 21 CFR Part 11: These three old friends are here to stay |author=June, T.M. |work=Quality Digest |date=July 2003 |accessdate=15 April 2020}}</ref> The retraction of guidance and change in policy, however, led many IT members in the pharmaceutical and life sciences industry in late 2004 to state one of the key problems they face as the lack of clear guidelines from the FDA about what is required for compliance.<ref name="SNSSurveyUKIT">{{cite web |url=http://snseurope.info/article/12833/Complying-with-US-Food-and-Drug-Administration(FDA)-data-regulations-is-proving-a-struggle-for-IT-departments-in-pharmaceutical-and-life-science-companies |title=Complying with US Food and Drug Administration(FDA) data regulations is proving a struggle for IT departments in pharmaceutical and life science companies |publisher=Storage Networking Solutions |date=17 November 2004 |accessdate=06 April 2013}}{{Dead link|April 2020}}</ref></div></td></tr>
<!-- diff cache key limswiki:diff::1.12:old-45456:rev-60567 -->
</table>Shawndouglashttps://www.limswiki.org/index.php?title=Laboratory_information_management_system&diff=60426&oldid=58795Laboratory information management system2024-03-28T01:18:53Z<p>Text replacement - "<a href="/index.php?title=Thermo_Scientific&action=edit&redlink=1" class="new" title="Thermo Scientific (page does not exist)">Thermo Scientific</a>" to "<a href="/index.php/Vendor:Thermo_Scientific" title="Vendor:Thermo Scientific">Thermo Scientific</a>"</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:18, 28 March 2024</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l155">Line 155:</td>
<td colspan="2" class="diff-lineno">Line 155:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>3. A LIMS is most competitive in group-centric settings (dealing with "batches" and "samples") that often deal with mostly anonymous research-specific laboratory data, whereas a LIS is usually most competitive in patient-centric settings (dealing with "subjects" and "specimens") and clinical labs.<ref name="analytica" /><ref name="lislims2">{{cite web |url=http://labsoftnews.typepad.com/lab_soft_news/2008/11/lis-vs-lims.html |title=LIS vs. LIMS: Some New Insights |author=Friedman, B. |work=Lab Soft News |date=19 November 2008 |accessdate=13 March 2024}}</ref><ref name="starlims">{{cite web |url=http://blog.starlims.com/2009/07/01/swimming-in-the-clinical-pool-why-lims-are-supplanting-old-school-clinical-lis-applications/ |archiveurl=https://web.archive.org/web/20110313145726/http://blog.starlims.com/2009/07/01/swimming-in-the-clinical-pool-why-lims-are-supplanting-old-school-clinical-lis-applications/ |title=Swimming in the Clinical Pool: Why LIMS are supplanting old-school clinical LIS applications |author=Hice, R. |publisher=STARLIMS Corporation |date=01 July 2009 |archivedate=13 March 2011 |accessdate=13 March 2024}}</ref></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>3. A LIMS is most competitive in group-centric settings (dealing with "batches" and "samples") that often deal with mostly anonymous research-specific laboratory data, whereas a LIS is usually most competitive in patient-centric settings (dealing with "subjects" and "specimens") and clinical labs.<ref name="analytica" /><ref name="lislims2">{{cite web |url=http://labsoftnews.typepad.com/lab_soft_news/2008/11/lis-vs-lims.html |title=LIS vs. LIMS: Some New Insights |author=Friedman, B. |work=Lab Soft News |date=19 November 2008 |accessdate=13 March 2024}}</ref><ref name="starlims">{{cite web |url=http://blog.starlims.com/2009/07/01/swimming-in-the-clinical-pool-why-lims-are-supplanting-old-school-clinical-lis-applications/ |archiveurl=https://web.archive.org/web/20110313145726/http://blog.starlims.com/2009/07/01/swimming-in-the-clinical-pool-why-lims-are-supplanting-old-school-clinical-lis-applications/ |title=Swimming in the Clinical Pool: Why LIMS are supplanting old-school clinical LIS applications |author=Hice, R. |publisher=STARLIMS Corporation |date=01 July 2009 |archivedate=13 March 2011 |accessdate=13 March 2024}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>However, these distinctions began to fade somewhat in the early 2010s as some LIMS vendors began to adopt the case-centric information management normally reserved for a LIS, blurring the lines between the two components further.<ref name="starlims" /> [[Thermo Scientific]]'s Clinical LIMS was an example of this merger of LIMS with LIS, with Dave Champagne, informatics vice president and general manager, stating: "Routine molecular diagnostics requires a convergence of the up-to-now separate systems that have managed work in the lab (the LIMS) and the clinic (the LIS). The industry is asking for, and the science is requiring, a single lab-centric solution that delivers patient-centric results."<ref name="ConvergeLimsLis">{{cite web |url=https://clpmag.com/lab-essentials/information-technology/convergence-of-lims-and-lis/ |title=Convergence of LIMS and LIS |author=Tufel, G. |work=Clinical Lab Products |publisher=MEDQOR |date=01 February 2012 |accessdate=13 March 2024}}</ref> [[Abbott Informatics Corporation]]'s STARLIMS product was another example of this LIMS/LIS merger.<ref name="StarlimsLimsLis" /> With the distinction between the two entities becoming less clear, discussions within the laboratory informatics community began to includes the question of whether or not the two entities should be considered the same.<ref name="LinkedInDifLisLims">{{cite web |url=https://www.linkedin.com/feed/update/urn:li:groupPost:2069898-98494737/ |title=What is the difference between a LIS and a LIMS? |author=Jones, J. |publisher=LinkedIn |date=March 2012 |accessdate=13 March 2024}}</ref><ref name="LinkedInLisLimsSame">{{cite web |url=http://www.linkedin.com/groups/Are-LIMS-LIS-same-thing-2069898.S.147132083 |title=Are LIMS and LIS the same thing? |author=Jones, John |publisher=LinkedIn |date=September 2012 |accessdate=07 November 2012}}{{Dead link}}</ref> {{As of|2024}}, vendors continue to recognize the historical differences between the two products while also continuing to acknowledge that some developed LIMS are taking on more of the clinical aspects usually reserved for a LIS.<ref name="AgilabFAQ">{{cite web |url=http://agilab.com/faq/ |archiveurl=https://web.archive.org/web/20190325075813/http://agilab.com/faq/ |title=FAQ: What is the difference between a LIMS and a medical laboratory quality system? |publisher=AgiLab SAS |archivedate=25 March 2019 |accessdate=13 March 2024}}</ref><ref name="ReisenwitzWhatIs17">{{cite web |url=https://www.capterra.com/resources/what-is-a-laboratory-information-management-system/ |title=What Is a Laboratory Information Management System? |author=Reisenwitz, C. |work=Capterra Medical Software Blog |publisher=Capterra, Inc |date=11 May 2017 |accessdate=13 March 2024}}</ref><ref name="CloudLISDifference16">{{cite web |url=https://cloudlims.com/lims-vs-lis/ |title=LIS vs LIMS: Uncover the Difference & Choose the Right Informatics Solution |publisher=CloudLIMS.com, LLC |date=12 October 2023 |accessdate=13 March 2024}}</ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>However, these distinctions began to fade somewhat in the early 2010s as some LIMS vendors began to adopt the case-centric information management normally reserved for a LIS, blurring the lines between the two components further.<ref name="starlims" /> [[<ins style="font-weight: bold; text-decoration: none;">Vendor:Thermo Scientific|</ins>Thermo Scientific]]'s Clinical LIMS was an example of this merger of LIMS with LIS, with Dave Champagne, informatics vice president and general manager, stating: "Routine molecular diagnostics requires a convergence of the up-to-now separate systems that have managed work in the lab (the LIMS) and the clinic (the LIS). The industry is asking for, and the science is requiring, a single lab-centric solution that delivers patient-centric results."<ref name="ConvergeLimsLis">{{cite web |url=https://clpmag.com/lab-essentials/information-technology/convergence-of-lims-and-lis/ |title=Convergence of LIMS and LIS |author=Tufel, G. |work=Clinical Lab Products |publisher=MEDQOR |date=01 February 2012 |accessdate=13 March 2024}}</ref> [[Abbott Informatics Corporation]]'s STARLIMS product was another example of this LIMS/LIS merger.<ref name="StarlimsLimsLis" /> With the distinction between the two entities becoming less clear, discussions within the laboratory informatics community began to includes the question of whether or not the two entities should be considered the same.<ref name="LinkedInDifLisLims">{{cite web |url=https://www.linkedin.com/feed/update/urn:li:groupPost:2069898-98494737/ |title=What is the difference between a LIS and a LIMS? |author=Jones, J. |publisher=LinkedIn |date=March 2012 |accessdate=13 March 2024}}</ref><ref name="LinkedInLisLimsSame">{{cite web |url=http://www.linkedin.com/groups/Are-LIMS-LIS-same-thing-2069898.S.147132083 |title=Are LIMS and LIS the same thing? |author=Jones, John |publisher=LinkedIn |date=September 2012 |accessdate=07 November 2012}}{{Dead link}}</ref> {{As of|2024}}, vendors continue to recognize the historical differences between the two products while also continuing to acknowledge that some developed LIMS are taking on more of the clinical aspects usually reserved for a LIS.<ref name="AgilabFAQ">{{cite web |url=http://agilab.com/faq/ |archiveurl=https://web.archive.org/web/20190325075813/http://agilab.com/faq/ |title=FAQ: What is the difference between a LIMS and a medical laboratory quality system? |publisher=AgiLab SAS |archivedate=25 March 2019 |accessdate=13 March 2024}}</ref><ref name="ReisenwitzWhatIs17">{{cite web |url=https://www.capterra.com/resources/what-is-a-laboratory-information-management-system/ |title=What Is a Laboratory Information Management System? |author=Reisenwitz, C. |work=Capterra Medical Software Blog |publisher=Capterra, Inc |date=11 May 2017 |accessdate=13 March 2024}}</ref><ref name="CloudLISDifference16">{{cite web |url=https://cloudlims.com/lims-vs-lis/ |title=LIS vs LIMS: Uncover the Difference & Choose the Right Informatics Solution |publisher=CloudLIMS.com, LLC |date=12 October 2023 |accessdate=13 March 2024}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Regulations, standards, and best practices affecting LIMS development and use==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Regulations, standards, and best practices affecting LIMS development and use==</div></td></tr>
<!-- diff cache key limswiki:diff::1.12:old-58795:rev-60426 -->
</table>Shawndouglashttps://www.limswiki.org/index.php?title=Laboratory_informatics&diff=60230&oldid=45409Laboratory informatics2024-03-27T19:13:54Z<p>Updated for 2024</p>
<a href="https://www.limswiki.org/index.php?title=Laboratory_informatics&diff=60230&oldid=45409">Show changes</a>Shawndouglashttps://www.limswiki.org/index.php?title=Abbott_Informatics_Corporation&diff=58871&oldid=0Abbott Informatics Corporation2024-03-27T18:55:52Z<p><a href="/index.php?title=User:Move_page_script&action=edit&redlink=1" class="new mw-userlink" title="User:Move page script (page does not exist)"><bdi>Move page script</bdi></a> moved page <a href="/index.php?title=Abbott_Informatics_Corporation&redirect=no&action=edit&redlink=1" class="new" title="Abbott Informatics Corporation (page does not exist)">Abbott Informatics Corporation</a> to <a href="/index.php/Vendor:Abbott_Informatics_Corporation" title="Vendor:Abbott Informatics Corporation">Vendor:Abbott Informatics Corporation</a> without leaving a redirect</p>
<p><b>New page</b></p><div>{{Infobox company<br />
|company_name = '''Abbott Informatics Corporation'''<br />
|company_logo = [[File:Vendor284.jpg|180px]]<br />
|company_type = Corporation<br />
|traded_as = <br />
|industry = [[Laboratory informatics]]<br />
|genre =<br />
|fate = Name change<br />
|predecessor =<br />
|successor = [[STARLIMS Corporation]]<br />
|company_slogan = <br />
|foundation = <br />
|founder = <br />
|defunct = 07 September 2022<ref name="SBizSTARLIMS22">{{cite web |url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=STARLIMS%20S151573&aggregateId=domp-s15157-c4d76982-d367-4d82-b5a2-f09bdd90c108 |title=STARLIMS Corporation |work=sunbiz.org |publisher=Florida Division of Corporations |date=07 February 2022 |accessdate=23 February 2022 |quote=Document # S15157}}</ref><br />
|location_city = Presidential Building, 4000 Hollywood Boulevard, Suite 333, South Hollywood, Florida<br />
|location_country = U.S.<br />
|locations = 49<br />
|area_served = Worldwide<br />
|key_people = <br />
|products = {{Collapsible list<br />
|framestyle=border:none; padding:0;<br />
|title=<small>Products list</small><br />
|1=<li>STARLIMS ELN<br />
|2=<li>STARLIMS SDMS<br />
|3=<li>STARLIMS LIMS}}<br />
|production =<br />
|service =<br />
|revenue = <br />
|operating_income = <br />
|net_income = <br />
|aum =<br />
|assets = <br />
|equity = <br />
|owner = <br />
|num_employees = <br />
|parent = Francisco Partners Management LP<br />
|divisions = <br />
|subsid =<br />
|homepage = [https://www.starlims.com/ starlims.com]<br />
|footnotes =<br />
|intl = Yes<br />
}}<br />
'''Abbott Informatics Corporation''' developed and distributed [[laboratory informatics]] software solutions. In February 2022, the company changed its legal name to [[STARLIMS Corporation]].<br />
<br />
==History==<br />
<br />
STARLIMS Technologies Ltd. was founded by Itschak Friedman and incorporated under the laws of the State of Israel in May 1986. In November 1993, STARLIMS completed an initial public offering of its ordinary shares, which traded on the Tel Aviv Stock Exchange.<ref name="SL20F">{{cite web |url=http://www.sec.gov/Archives/edgar/data/1396278/000117891309000676/zk96493.htm |title=Securities and Exchange Commission file number: 001-33487 |author=STARLIMS Technologies Ltd |publisher=U.S. Securities and Exchange Commission |date=25 March 2009 |accessdate=26 November 2012}}</ref> The company made a public offering in the United States in May 2007 and was introduced to the NASDAQ under the Stock Market under the symbol LIMS.<ref name="SL20F" /><ref name="SLMWStock">{{cite web |url=http://www.marketwatch.com/story/starlims-tech-files-37-mln-ipo |title=Starlims Tech files $37 mln IPO |author=Gelsi, Steve |publisher=MarketWatch |date=04 May 2007 |accessdate=26 November 2012}}</ref> <br />
<br />
In August 2008, the Company announced the establishment of STARLIMS Europe as a result of the May 2008 acquisition of its United Kingdom partner Lab Data Management Ltd., based in Bolton, Greater Manchester.<ref name="SLEurope">{{cite web |url=http://www.istockanalyst.com/article/viewiStockNews/articleid/2512919 |title=STARLIMS Consolidates Direct Presence in Europe; Hires LIMS Veteran Joe Peden to Head STARLIMS Europe |publisher=iStockAnalyst |date=14 August 2008 |accessdate=26 November 2012}}</ref> <br />
<br />
In late 2009 it was revealed [[Abbott Laboratories, Inc.]] would acquire all outstanding equity of STARLIMS Technologies.<ref name="AbbottAqGlobe">{{cite web |url=http://www.globes.co.il/serveen/globes/docview.asp?did=1000522537&fid=1725 |title=Abbott Labs buys StarLIMS |author=Weinreb, Gali |publisher=GLOBES |date=15 December 2009 |accessdate=26 November 2012}}</ref>The deal was finalized on March 22, 2010 for a published cost of $123 million.<ref name="AbbottAqCBR">{{cite web |url=http://www.cbronline.com/news/abbott_takes_over_starlims_technologies_100323 |title=Abbott Takes Over Starlims Technologies |publisher=CBR |date=22 March 2010 |accessdate=26 November 2012}}</ref> STARLIMS Corporation continued to act as a subsidiary of Abbot Labotatories.<br />
<br />
On May 30, 2014, STARLIMS Corporation officially changed the name of its Florida-based headquarters to [[Abbot Informatics Corporation]].<ref name="FDSNameChange">{{cite web |url=http://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2014%5C0604%5C00126887.Tif&documentNumber=S15157 |format=PDF |title=Articles of Amendment to Articles of Incorporation of Starlims Corporation |publisher=Florida Department of State |date=30 May 2014 |accessdate=24 March 2016}}</ref> However, it wasn't until October 2015 that the company shifted its web presence, dropping the STARLIMS Corporation name in full.<ref name="STARSep15Arch">{{cite web |url=http://www.starlims.com/en-us/home |archiveurl=https://web.archive.org/web/20150917024509/http://www.starlims.com/en-us/home |title=STARLIMS: Creating Smarter Labs |archivedate=17 September 2015 |accessdate=24 March 2016}}</ref><ref name="AIOct15Arch">{{cite web |url=https://www.abbottinformatics.com/us/home |archiveurl=https://web.archive.org/web/20151023002054/https://www.abbottinformatics.com/us/home |title=STARLIMS.com is now AbbottInformatics.com |archivedate=23 October 2015 |accessdate=24 March 2016}}</ref><br />
<br />
On July 7, 2021, Francisco Partners Management LP announced that it had "signed a definitive agreement to acquire the STARLIMS informatics product suite and related business assets from Abbott."<ref name="BWFrancisco21">{{cite web |url=https://www.businesswire.com/news/home/20210707005603/en/Francisco-Partners-to-Acquire-STARLIMS |title=Francisco Partners to Acquire STARLIMS |author=Francisco Partners Management LP |work=BusinessWire |date=07 July 2021 |accessdate=14 July 2021}}</ref> The company noted that "STARLIMS has thrived within Abbott’s informatics business, and we are excited to partner with the employees and customers<ref name="BWFrancisco21" />," suggesting Abbott Informatics Corporation and its personnel may be involved in the acquisition.<br />
<br />
Abbott Informatics officially changed its legal name to match its doing business name, finalizing the use of its prior name "STARLIMS Corporation" on February 7, 2022 with the state of Florida.<ref name="SBizSTARLIMS22" /><br />
<br />
==Technology and products==<br />
<br />
===STARLIMS ELN, SDMS, and LIMS===<br />
{{As of|February 2022}}, these products and others are still marketed. See the [[STARLIMS Corporation]] page for more information.<br />
<br />
==References==<br />
<references/><br />
<br />
<!---Place all category tags here--><br />
[[Category:Inactive ELN vendor]]<br />
[[Category:Inactive LIMS vendor]]<br />
[[Category:Inactive SDMS vendor]]<br />
[[Category:Inactive vendors]]</div>Move page script